Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ImmunoHorizons 2021-02, Vol.5 (2), p.59-69
Hauptverfasser: Luangrath, Mitchell A, Schmidt, Megan E, Hartwig, Stacey M, Varga, Steven M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 69
container_issue 2
container_start_page 59
container_title ImmunoHorizons
container_volume 5
creator Luangrath, Mitchell A
Schmidt, Megan E
Hartwig, Stacey M
Varga, Steven M
description Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection.
doi_str_mv 10.4049/immunohorizons.2000067
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2486462073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</originalsourceid><addsrcrecordid>eNpVkVtr3DAQhUVpaUKavxD02Ben9uhmvxTC0ktgQ0u77auY2ONdFVvaSnJg--ujkG1I9DICne-MZg5jF019KWvZfXDzvPiwC9H9Cz5dQl2ONq_YKSgjKmMEvH52P2HnKf0pEmhkbYR8y06EUEKDUKdsu3EpLVT9oOQG8pnf0BzigW_4iqYpced53hFfL36b-PcYMvWZ4xadT5lf9UsmXtC9i5gfsJ8H3x-yw4n_dnFJ_NqPBXDBv2NvRpwSnR_rGfv1-dNm9bVaf_tyvbpaV72AzlSd0bIzAypNRgEYaYbbEVAqbLFpJaBG06A0qIA0mKYm05gWBj22RKobxRn7-Oi7X25nGvoyUsTJ7qObMR5sQGdfvni3s9twZ1voOiWhGLw_GsTwd6GU7exSX3aBnsKSLMhWSw1lkUWqH6V9DClFGp_aNLV9CMq-DMoegyrgxfNPPmH_YxH3A1CVYg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486462073</pqid></control><display><type>article</type><title>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Luangrath, Mitchell A ; Schmidt, Megan E ; Hartwig, Stacey M ; Varga, Steven M</creator><creatorcontrib>Luangrath, Mitchell A ; Schmidt, Megan E ; Hartwig, Stacey M ; Varga, Steven M</creatorcontrib><description>Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection.</description><identifier>ISSN: 2573-7732</identifier><identifier>EISSN: 2573-7732</identifier><identifier>DOI: 10.4049/immunohorizons.2000067</identifier><identifier>PMID: 33536235</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Epitopes, T-Lymphocyte - administration &amp; dosage ; Epitopes, T-Lymphocyte - genetics ; Epitopes, T-Lymphocyte - immunology ; Female ; Fingolimod Hydrochloride - pharmacology ; Immunologic Memory ; Influenza Vaccines - administration &amp; dosage ; Influenza Vaccines - genetics ; Influenza Vaccines - immunology ; Lung - immunology ; Lung - virology ; Memory T Cells - drug effects ; Memory T Cells - immunology ; Mice ; Mice, Inbred BALB C ; Respiratory Syncytial Virus Infections - immunology ; Respiratory Syncytial Virus Infections - prevention &amp; control ; Respiratory Syncytial Viruses - immunology ; Vaccines, Synthetic - administration &amp; dosage ; Vaccines, Synthetic - immunology</subject><ispartof>ImmunoHorizons, 2021-02, Vol.5 (2), p.59-69</ispartof><rights>Copyright © 2021 The Authors.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</citedby><cites>FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</cites><orcidid>0000-0001-7332-4290 ; 0000-0002-0967-7937</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,860,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33536235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luangrath, Mitchell A</creatorcontrib><creatorcontrib>Schmidt, Megan E</creatorcontrib><creatorcontrib>Hartwig, Stacey M</creatorcontrib><creatorcontrib>Varga, Steven M</creatorcontrib><title>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</title><title>ImmunoHorizons</title><addtitle>Immunohorizons</addtitle><description>Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection.</description><subject>Animals</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Epitopes, T-Lymphocyte - administration &amp; dosage</subject><subject>Epitopes, T-Lymphocyte - genetics</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Female</subject><subject>Fingolimod Hydrochloride - pharmacology</subject><subject>Immunologic Memory</subject><subject>Influenza Vaccines - administration &amp; dosage</subject><subject>Influenza Vaccines - genetics</subject><subject>Influenza Vaccines - immunology</subject><subject>Lung - immunology</subject><subject>Lung - virology</subject><subject>Memory T Cells - drug effects</subject><subject>Memory T Cells - immunology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Respiratory Syncytial Virus Infections - immunology</subject><subject>Respiratory Syncytial Virus Infections - prevention &amp; control</subject><subject>Respiratory Syncytial Viruses - immunology</subject><subject>Vaccines, Synthetic - administration &amp; dosage</subject><subject>Vaccines, Synthetic - immunology</subject><issn>2573-7732</issn><issn>2573-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVtr3DAQhUVpaUKavxD02Ben9uhmvxTC0ktgQ0u77auY2ONdFVvaSnJg--ujkG1I9DICne-MZg5jF019KWvZfXDzvPiwC9H9Cz5dQl2ONq_YKSgjKmMEvH52P2HnKf0pEmhkbYR8y06EUEKDUKdsu3EpLVT9oOQG8pnf0BzigW_4iqYpced53hFfL36b-PcYMvWZ4xadT5lf9UsmXtC9i5gfsJ8H3x-yw4n_dnFJ_NqPBXDBv2NvRpwSnR_rGfv1-dNm9bVaf_tyvbpaV72AzlSd0bIzAypNRgEYaYbbEVAqbLFpJaBG06A0qIA0mKYm05gWBj22RKobxRn7-Oi7X25nGvoyUsTJ7qObMR5sQGdfvni3s9twZ1voOiWhGLw_GsTwd6GU7exSX3aBnsKSLMhWSw1lkUWqH6V9DClFGp_aNLV9CMq-DMoegyrgxfNPPmH_YxH3A1CVYg</recordid><startdate>20210203</startdate><enddate>20210203</enddate><creator>Luangrath, Mitchell A</creator><creator>Schmidt, Megan E</creator><creator>Hartwig, Stacey M</creator><creator>Varga, Steven M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7332-4290</orcidid><orcidid>https://orcid.org/0000-0002-0967-7937</orcidid></search><sort><creationdate>20210203</creationdate><title>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</title><author>Luangrath, Mitchell A ; Schmidt, Megan E ; Hartwig, Stacey M ; Varga, Steven M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Epitopes, T-Lymphocyte - administration &amp; dosage</topic><topic>Epitopes, T-Lymphocyte - genetics</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Female</topic><topic>Fingolimod Hydrochloride - pharmacology</topic><topic>Immunologic Memory</topic><topic>Influenza Vaccines - administration &amp; dosage</topic><topic>Influenza Vaccines - genetics</topic><topic>Influenza Vaccines - immunology</topic><topic>Lung - immunology</topic><topic>Lung - virology</topic><topic>Memory T Cells - drug effects</topic><topic>Memory T Cells - immunology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Respiratory Syncytial Virus Infections - immunology</topic><topic>Respiratory Syncytial Virus Infections - prevention &amp; control</topic><topic>Respiratory Syncytial Viruses - immunology</topic><topic>Vaccines, Synthetic - administration &amp; dosage</topic><topic>Vaccines, Synthetic - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luangrath, Mitchell A</creatorcontrib><creatorcontrib>Schmidt, Megan E</creatorcontrib><creatorcontrib>Hartwig, Stacey M</creatorcontrib><creatorcontrib>Varga, Steven M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ImmunoHorizons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luangrath, Mitchell A</au><au>Schmidt, Megan E</au><au>Hartwig, Stacey M</au><au>Varga, Steven M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</atitle><jtitle>ImmunoHorizons</jtitle><addtitle>Immunohorizons</addtitle><date>2021-02-03</date><risdate>2021</risdate><volume>5</volume><issue>2</issue><spage>59</spage><epage>69</epage><pages>59-69</pages><issn>2573-7732</issn><eissn>2573-7732</eissn><abstract>Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection.</abstract><cop>United States</cop><pmid>33536235</pmid><doi>10.4049/immunohorizons.2000067</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7332-4290</orcidid><orcidid>https://orcid.org/0000-0002-0967-7937</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2573-7732
ispartof ImmunoHorizons, 2021-02, Vol.5 (2), p.59-69
issn 2573-7732
2573-7732
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299542
source MEDLINE; DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals
subjects Animals
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Epitopes, T-Lymphocyte - administration & dosage
Epitopes, T-Lymphocyte - genetics
Epitopes, T-Lymphocyte - immunology
Female
Fingolimod Hydrochloride - pharmacology
Immunologic Memory
Influenza Vaccines - administration & dosage
Influenza Vaccines - genetics
Influenza Vaccines - immunology
Lung - immunology
Lung - virology
Memory T Cells - drug effects
Memory T Cells - immunology
Mice
Mice, Inbred BALB C
Respiratory Syncytial Virus Infections - immunology
Respiratory Syncytial Virus Infections - prevention & control
Respiratory Syncytial Viruses - immunology
Vaccines, Synthetic - administration & dosage
Vaccines, Synthetic - immunology
title Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A46%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tissue-Resident%20Memory%20T%20Cells%20in%20the%20Lungs%20Protect%20against%20Acute%20Respiratory%20Syncytial%20Virus%20Infection&rft.jtitle=ImmunoHorizons&rft.au=Luangrath,%20Mitchell%20A&rft.date=2021-02-03&rft.volume=5&rft.issue=2&rft.spage=59&rft.epage=69&rft.pages=59-69&rft.issn=2573-7732&rft.eissn=2573-7732&rft_id=info:doi/10.4049/immunohorizons.2000067&rft_dat=%3Cproquest_pubme%3E2486462073%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486462073&rft_id=info:pmid/33536235&rfr_iscdi=true